An Open label multi- facilities cooperation randomized control trial to verify renoprotective effects of Aliskiren treatment in the chronic kidney disease (CKD).
Phase of Trial: Phase IV
Latest Information Update: 08 Jun 2015
At a glance
- Drugs Aliskiren (Primary) ; Antihypertensives
- Indications Hypertension
- Focus Pharmacodynamics
- 09 Jan 2012 New trial record